Molecules/TECLISTAMAB

TECLISTAMAB

Molecular Identity

AntibodyApprovedFirst approved 2022

Mechanism of action: T cell surface glycoprotein CD3 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

BCMAxCD3JNJ 64007957JNJ-64007957TECLISTAMABTECLISTAMAB CQYVTECLISTAMAB-CQYVTecvayli

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to TECLISTAMAB

Loading drug network...